155 related articles for article (PubMed ID: 19949903)
1. Effect of cyclodextrin complexation on the aqueous solubility and solubility/dose ratio of praziquantel.
Maragos S; Archontaki H; Macheras P; Valsami G
AAPS PharmSciTech; 2009; 10(4):1444-51. PubMed ID: 19949903
[TBL] [Abstract][Full Text] [Related]
2. Investigation of Praziquantel/Cyclodextrin Inclusion Complexation by NMR and LC-HRMS/MS: Mechanism, Solubility, Chemical Stability, and Degradation Products.
Špehar TK; Pocrnić M; Klarić D; Bertoša B; Čikoš A; Jug M; Padovan J; Dragojević S; Galić N
Mol Pharm; 2021 Nov; 18(11):4210-4223. PubMed ID: 34670371
[TBL] [Abstract][Full Text] [Related]
3. Theoretical and experimental study of a praziquantel and beta-cyclodextrin inclusion complex using molecular mechanic calculations and H1-nuclear magnetic resonance.
de Jesus MB; de Matos Alves Pinto L; Fraceto LF; Takahata Y; Lino AC; Jaime C; de Paula E
J Pharm Biomed Anal; 2006 Jun; 41(4):1428-32. PubMed ID: 16678375
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical characterization of praziquantel cocrystals and cyclodextrin complexes prepared by grinding.
Cugovčan M; Jablan J; Lovrić J; Cinčić D; Galić N; Jug M
J Pharm Biomed Anal; 2017 Apr; 137():42-53. PubMed ID: 28092854
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations.
Münster M; Mohamed-Ahmed AHA; Immohr LI; Schoch C; Schmidt C; Tuleu C; Breitkreutz J
Int J Pharm; 2017 Aug; 529(1-2):310-318. PubMed ID: 28689966
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.
de Jesus MB; Pinto Lde M; Fraceto LF; Magalhães LA; Zanotti-Magalhães EM; de Paula E
J Drug Target; 2010 Jan; 18(1):21-6. PubMed ID: 19624246
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins.
Becket G; Schep LJ; Tan MY
Int J Pharm; 1999 Mar; 179(1):65-71. PubMed ID: 10053203
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the guest-host interactions and complex formation of praziquantel and cyclodextrin derivatives by (13)C and (15)N solid-state NMR spectroscopy.
Arrúa EC; Ferreira MJ; Salomon CJ; Nunes TG
Int J Pharm; 2015 Dec; 496(2):812-21. PubMed ID: 26602291
[TBL] [Abstract][Full Text] [Related]
9. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
10. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
11. Improvement in Solubility-Permeability Interplay of Psoralens from
Machado RD; Silva JCG; Silva LAD; Oliveira GAR; Lião LM; Lima EM; de Morais MC; da Conceição EC; Rezende KR
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889459
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
[TBL] [Abstract][Full Text] [Related]
13. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
Yurtdaş-Kırımlıoğlu G
Drug Dev Ind Pharm; 2021 Aug; 47(8):1261-1278. PubMed ID: 34606394
[TBL] [Abstract][Full Text] [Related]
14. Thymol/cyclodextrin inclusion complex nanofibrous webs: Enhanced water solubility, high thermal stability and antioxidant property of thymol.
Celebioglu A; Yildiz ZI; Uyar T
Food Res Int; 2018 Apr; 106():280-290. PubMed ID: 29579928
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
[TBL] [Abstract][Full Text] [Related]
16. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
17. Empirical, thermodynamic and quantum-chemical investigations of inclusion complexation between flavanones and (2-hydroxypropyl)-cyclodextrins.
Liu B; Li W; Nguyen TA; Zhao J
Food Chem; 2012 Sep; 134(2):926-32. PubMed ID: 23107709
[TBL] [Abstract][Full Text] [Related]
18. Unexpected solvent impact in the crystallinity of praziquantel/poly(vinylpyrrolidone) formulations. A solubility, DSC and solid-state NMR study.
Costa ED; Priotti J; Orlandi S; Leonardi D; Lamas MC; Nunes TG; Diogo HP; Salomon CJ; Ferreira MJ
Int J Pharm; 2016 Sep; 511(2):983-93. PubMed ID: 27506511
[TBL] [Abstract][Full Text] [Related]
19. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
[TBL] [Abstract][Full Text] [Related]
20. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]